| 2025 | Rapamycin Modulates the Polarisation of CD4+ T Cells Towards TH1 Cells in Patients with Active Granulomatosis with Polyangiitis and Microscopic Polyangiitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Plasma Exchange as an Adjunctive Therapeutic Option for Severe and Refractory Antineutrophil Cytoplasmic Antibody-Negative Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| MEDICINA-LITHUANIA |
| 2025 | Utility of serum cystatin C measured at diagnosis in evaluating cross-sectional activity and predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL RHEUMATOLOGY |
| 2025 | Initial Circulating CD138 Predicts End-Stage Kidney Disease in Patients with Microscopic Polyangiitis
| YONSEI MEDICAL JOURNAL |
| 2025 | Is Chest Imaging Alone Adequate for Diagnosing Interstitial Lung Disease in Microscopic Polyangiitis Based on the 2022 Criteria?
| YONSEI MEDICAL JOURNAL |
| 2025 | Lower Myeloperoxidase-ANCA Titres at Diagnosis Are Associated with End-Stage Kidney Disease Progression During Follow-Up in Rituximab-Treated Patients with Microscopic Polyangiitis | MEDICINA-LITHUANIA |
| 2025 | Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer
| GUT AND LIVER |
| 2025 | Development of a new scoring system for predicting recurrent thrombosis in patients with antiphospholipid syndrome | ADVANCES IN RHEUMATOLOGY |
| 2025 | Clinical Implications of Point-of-Care Measurement of Adalimumab Concentration and Anti-Adalimumab Antibodies in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2025 | Application of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria to patients fulfilling the 2006 revised Sapporo criteria | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2025 | Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort
| SEMINARS IN ARTHRITIS AND RHEUMATISM |
| 2025 | A new formula consisting of the five-factor score and earliest vasculitis damage index at diagnosis for predicting poor outcomes of antineutrophil cytoplasmic antibody-associated vasculitis
| FRONTIERS IN MEDICINE |
| 2025 | Unraveling the differential diagnosis of hyperferritinemia: insights from a retrospective study at a tertiary care hospital | POSTGRADUATE MEDICAL JOURNAL |
| 2025 | Impact of Early MPO-ANCA Positivity on Unique Clinical Features in Korean Patients with EGPA: A Single-Centre Cohort Study
| MEDICINA-LITHUANIA |
| 2025 | Clinical Significance of Peripheral Arterial Disease Evaluation in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2025 | Adjusted Global Antiphospholipid Syndrome Score Is Associated with End-Stage Kidney Disease in Patients with ANCA-Associated Vasculitis: A Single-Centre Pilot Study
| YONSEI MEDICAL JOURNAL |
| 2025 | Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study
| ARTHRITIS RESEARCH & THERAPY |
| 2025 | Clinical perspective on serum periostin in antineutrophil-cytoplasmic antibody-associated vasculitis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2025 | Immunologic Response and Effects of COVID-19 Vaccines in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| YONSEI MEDICAL JOURNAL |
| 2025 | Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease | JOURNAL OF RHEUMATOLOGY |
| 2025 | Overlap Syndrome of Primary Sjögren Syndrome with Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Based on the American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology (EULAR) Criteria
| DIAGNOSTICS |
| 2025 | Validation of the 2022 ACR/EULAR classification criteria for giant cell arteritis in Korean patients with giant cell arteritis | MODERN RHEUMATOLOGY |
| 2025 | Serum Wnt3A levels are significantly associated with cross-sectional vasculitis activity and end-stage kidney disease during follow-up of patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2025 | Clinical Utility of Serum sCD200/sCD200R Ratios in Predicting Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Remnant Cholesterol Levels at Diagnosis May Predict Acute Coronary Syndrome Occurrence During Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Circulating GDF15 May Estimate Vasculitis Activity and Predict Poor Outcomes During the Disease Course of ANCA-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Serum glutathione peroxidase-3 concentration at diagnosis as a biomarker for assessing disease activity and damage of antineutrophil cytoplasmic antibody-associated vasculitis at diagnosis
| FRONTIERS IN MOLECULAR BIOSCIENCES |
| 2025 | Prediction potential of serum sulfatide levels at diagnosis for end-stage kidney disease progression in ANCA-associated vasculitis
| MEDICINE |
| 2025 | A New Formula Consisting of the Initial Independent Predictors of All-Cause Mortality Derived from a Single-Centre Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Reclassification of the overlap syndrome of Behçet’s disease and antineutrophil cytoplasmic antibody-associated vasculitis in patients with Behçet’s disease
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2024 | Serum Soluble Receptors for Advanced Glycation End-Products May Predict Mortality in Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| YONSEI MEDICAL JOURNAL |
| 2024 | Serum Glial Fibrillary Acidic Protein Can Predict Cross-Sectional Vasculitis Activity by Reflecting Renal Involvement in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2024 | Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis
| ARTHRITIS RESEARCH & THERAPY |
| 2024 | Clinical Significance of Overlap Syndrome of Histologically Confirmed Lupus Nephritis with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
| 2024 | Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria | MODERN RHEUMATOLOGY |
| 2024 | Circulating Malondialdehyde Is a Potential Biomarker for Predicting All-Cause Mortality during Follow-Up by Reflecting Comprehensive Inflammation at Diagnosis in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2024 | The Clinical Utility of Serum Alpha-1-Acid Glycoprotein in Reflecting the Cross-Sectional Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Centre Retrospective Study
| MEDICINA-LITHUANIA |
| 2024 | The monocyte-to-high-density lipoprotein-cholesterol ratio at diagnosis is associated with cerebrovascular accident during follow-up in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| Journal of Rheumatic Diseases |
| 2024 | Soluble programmed death-1 is a useful indicator for mortality in patients with adult-onset Still's disease | INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES |
| 2024 | Adipose Tissue-Derived Mesenchymal Stem Cell Inhibits Osteoclast Differentiation through Tumor Necrosis Factor Stimulated Gene-6 | TISSUE ENGINEERING AND REGENERATIVE MEDICINE |
| 2024 | Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2024 | First-year cumulative myeloperoxidase-ANCA titres are associated with all-cause mortality in patients with microscopic polyangiitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2024 | Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
| 2024 | Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
| 2024 | Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis : Correlation with disease activity | ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2024 | Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic
| ZEITSCHRIFT FUR RHEUMATOLOGIE |
| 2024 | Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort | SEMINARS IN ARTHRITIS AND RHEUMATISM |
| 2024 | Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study | CLINICAL RHEUMATOLOGY |
| 2023 | Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis
| ARTHRITIS RESEARCH & THERAPY |
(7405369878)
